health

The funds will support the work of Dr. John Belperio and Dr. Joseph Lynch III in the division of pulmonary and critical care medicine.

Veterans, their family members, program staff and supporters, walked behind a huge banner on the streets of Manhattan.

The NIH awarded $27.2 million to UCLA to lead the new phase of an effort to enhance diversity in the biomedical workforce.

Collaboration to be kicked off at leukemia and lymphoma fundraiser Nov. 9.

UCLA’s Dr. Sandra Loo says an FDA-approved device is an effective alternative to non-stimulant medications.

UCLA graduate student Cody Aros is helping make science and medicine more inclusive for LGBTQ-identifying people.

UCLA researchers find that the brain processes fear differently after injury.

Nearly 65 campus departments participate in the Halloween fun.

The study highlights the need to teach consumers about the dangers of some drug interactions.

Funds from California’s stem cell agency will support research on a blinding eye disease, cancer and an immune disorder.

The funds will help advance work in diagnosis, prognosis and treatment of the disease

The study demonstrates that PET imaging can be used to read mitochondrial activity in lung tumors.

Dr. Eric Kleerup explains how wildfires affect air quality and what precautions people can take to limit exposure to smoke and other fire-generated toxins.

Researchers created an app that allowed them to study body self-perceptions.

The results also show key findings in non-cigarette tobacco use, mental health and well-being.

Identifying the characteristics of dementia that are caused by traumatic brain injury could prevent people from being misdiagnosed with Alzheimer’s disease.

Dr. Denise Aberle and Dr. Carol Mangione have earned one of the highest honors in health and medicine.

The study, conducted in mice, is the first to show that creatine uptake is critical to the anti-tumor activities of what is known as killer T cells, the foot soldiers of the immune system.

UCLA research identifies a potential strategy that may lead to treatment for the disorder.

In most people with chronic myelogenous leukemia, cancerous stem cells remain in the body for years after remission, and the cancer can recur.

The discovery may help lead to a new understanding of mitochondria’s roles in aging, disease and medical complications, the UCLA researchers said.

When reviewers were subspeciality-trained, misclassification rates were the lowest.

UCLA professor Dr. Michelle Bholat spoke at Zócalo about the need to license more foreign-trained doctors and of how hospitals are adapting to the cultures of patients.

The lack of coordination among doctors, social workers and other health providers has been one of the health system’s longstanding challenges.

The finding suggests that predicting how a person’s cancer will evolve may lie in their inherited genetic material.